DEF 14A: EBR Systems Seeks Reverse Split, Ratifies A$75.9M Raise

EBR Systems, Inc. calls a Special Meeting to approve a reverse stock split, ratify a A$75.9 million capital raise, and potentially adjourn the meeting.

Summary

• A Special Meeting of Stockholders is scheduled for March 12, 2026 (Australia) / March 11, 2026 (U.S.) to vote on three key proposals.
• Proposal 1 seeks approval for amendments to the Company's Certificate of Incorporation to effect a reverse stock split (share consolidation) at a ratio ranging from 1-for-5 to 1-for-20, at the Board's discretion. CHESS Depositary Interests (CDIs) will not be consolidated, but their transmutation ratio to shares will change proportionally.
• Proposal 2 aims to ratify the issuance of 55,900,000 CDIs (equivalent to 55,900,000 shares) at an issue price of A$1.00 per CDI, which occurred on May 27, 2025, as part of an Institutional Placement. This ratification is for compliance with Australian Securities Exchange (ASX) Listing Rule 7.4.
• Proposal 3 requests approval for the adjournment of the Special Meeting, if necessary, to solicit additional proxies should there be insufficient votes for Proposals 1 and 2.
• The company previously raised approximately A$75.9 million in May and June 2025, comprising A$55.9 million from the Institutional Placement and A$20.0 million from a Security Purchase Plan.
• Proceeds from the capital raise are designated for advancing the commercialization strategy of EBR's novel WiSE CRT system, scaling up manufacturing and sales capabilities, research and development, and general administrative and working capital.
• As of December 31, 2025, the company had 450,259,169 shares of common stock outstanding, including those underlying CDIs.

Sentiment

Score: 5

Explanation: The company is proactively addressing capital structure and financing needs through a proposed reverse stock split and has successfully completed a significant capital raise. These actions are crucial for supporting the commercialization strategy and ensuring operational continuity. However, the necessity of a reverse stock split often indicates a low share price, and the explicit warning about the need for future capital to continue as a going concern highlights ongoing financial challenges and potential future dilution for shareholders.

Positives

• Successfully completed a capital raise of approximately A$75.9 million in May and June 2025, providing crucial funding for commercialization and growth initiatives.
• The Board is proactively seeking stockholder approval for a flexible reverse stock split ratio (1-for-5 to 1-for-20) to manage capital structure and potentially improve market perception.
• Ratification of the prior CDI issuance under ASX Listing Rule 7.4 will restore the company's 15% placement capacity, providing flexibility for future equity issuances without immediate stockholder approval.

Negatives

• The necessity of a reverse stock split often indicates a low share price, which can be viewed negatively by investors and may not guarantee a sustained increase in share price.
• The proposed reverse stock split, by increasing authorized but unissued shares, creates the potential for significant dilution to current stockholders if additional equity is issued in the future.
• The company explicitly states that the incurrence of debt financing could result in additional debt service obligations and restrictive operating and financial covenants, which could be adverse to current stakeholders.
• There is no assurance that the reverse stock split will not adversely impact the market price of the company's CDIs, as some investors may view it negatively.

Risks

• There is no assurance that future equity or debt financing will be available in amounts or on terms acceptable to the company, if at all, or that the company will be able to raise capital to fund its operations and continue as a going concern.
• The effect of the reverse stock split on the market price of the company's CDIs cannot be accurately predicted and may adversely impact the market price.
• The increased proportion of authorized but unissued shares resulting from the reverse stock split could be considered an anti-takeover measure, potentially making it more difficult for stockholders to change the Board's composition or for tender offers to succeed.
• Future issuance of additional shares of common stock will reduce current stockholders' percentage ownership interest and, in the absence of proportionate increases in earnings and book value, would dilute projected future earnings per share and book value per share.

Future Outlook

The company intends to explore various potential financing strategies, including equity or debt financing, to support the growth of its business and execution of its business plan. The availability of such financing is contingent on the continued execution of its long-term business plan, demonstrating a path to long-term profitable growth, and prevailing market conditions. There is no assurance that such financing will be available on acceptable terms or at all, and failure to raise additional capital could materially adversely affect liquidity and business objectives.

Management Comments

• "The Board believes it is critically important for the Company to maintain its flexibility in accessing the equity capital markets."
• "We intend to explore different potential financing strategies to help support the growth of our business and execution of our business plan, including equity or debt financing..."
• "There can be no assurance that such equity or debt financing will be available in amounts or on terms acceptable to us, if at all, or that we will be able to raise capital to fund our operations and to continue as a going concern."
• "Nonetheless, we believe that failure to raise additional capital through equity or debt financing could have a material adverse effect on our ability to meet our shortand long-term liquidity needs and achieve our business objectives."
• "The Board does not intend for the reverse stock split to have any anti-takeover effects."
• "Our Board is not presently aware of any attempt to acquire control of the Company, and the Reverse Stock Split proposal is not part of any plan by our Board to recommend or implement a series of anti-takeover measures."

Industry Context

The filing focuses on internal corporate actions related to capital structure and financing, rather than providing specific analysis of broader industry trends or competitive landscape. The need for capital raising and a reverse stock split suggests the company is navigating the typical challenges of commercializing a novel medical device, which often requires significant and sustained investment.

Corporate Governance

Stakeholder Impact

• Shareholders: Will own a reduced number of shares post-reverse stock split, but their percentage ownership interest will remain largely unchanged (subject to fractional share rounding). They face potential dilution from future equity issuances facilitated by the increased pool of authorized shares.
• CDI Holders: The number of CDIs held will not be consolidated, but the transmutation ratio of CDIs to shares will change proportionally to the reverse stock split ratio, affecting the number of CDIs required to represent one underlying share or to direct a vote.
• Employees, Consultants, and Directors (holding equity awards): Outstanding stock options and RSUs will be proportionately adjusted in terms of the number of shares issuable and their exercise prices.
• Warrant Holders: The exercise price and the number of shares issuable upon exercise of outstanding warrants will be proportionately adjusted to reflect the reverse stock split.

Next Steps

• Stockholders are to vote on the proposed amendments for the reverse stock split, the ratification of security issuances, and the adjournment proposal at the Special Meeting on March 12, 2026 (Australia) / March 11, 2026 (U.S.).
• If Proposal 1 is approved, the Board of Directors will determine the exact reverse stock split ratio (within the 1-for-5 to 1-for-20 range) and the effective date.
• The company will make a public announcement detailing the reverse stock split ratio and implementation timetable if the Board decides to proceed.
• Final voting results from the Special Meeting will be released on the ASX and published in a current report on Form 8-K within four business days after the meeting.
• The company plans to continue exploring different potential financing strategies (equity or debt) to support its business growth and long-term objectives.

Key Dates

Recommendation

The company is taking necessary steps to improve its capital structure and ensure future financing flexibility, which is a positive for long-term viability. The recent capital raise provides immediate funding for commercialization. However, the need for a reverse stock split often indicates underlying share price weakness, and the potential for future dilution from additional capital raises presents a risk. Investors should hold to observe the execution of the commercialization strategy and the impact of the reverse stock split on market perception and share price stability.

Keywords

Reverse Stock Split, Share Consolidation, Capital Raise, Institutional Placement, ASX Listing Rule 7.4, Proxy Statement, Corporate Governance, Equity Financing, CDI, EBR Systems, SEC Filing